DR. YURI KASHIV

Dr. Swarna Biseria Gupta, DR.KISHORI LAL GUPTA

AIM-TO ASSESS PREVALENCE OF BLEPHAROSPASM.

,TO EVALUATE THE SAFETY, EFFICACY AND RISK FACTORS OF BOTULINUMA TOXIN

METHOD-15 PATIENTS OF ESSENTIAL BLEPHAROSPASM AND TWO WITH HEMIFACIAL SPASM, RECEIVED 12.5 UNIT

OF BOTULINUM TOXIN AT EACH SESSION IN EYE LIDS AND EYE BROWS. INJECTIONS REPEATED AS PER

NEED AND SEVERITY OF SPASM, SIDE EFFECTS WERE TAKEN CARE. RELXATION OF SPASM NOTICED.

FOLLOW UP DONE FOR ONE YEAR.

RESULTS–AFTER INJECTION TRANSIENT DECREASE IN SPASM OF ORBICULARIS MUSCLE NOTICED, RELIEF LASTED

AT LEAST F0R 12 WKS, MILD SIDE EFFECTS NOTICED AS ITCHING,IRRITATION,REDUCED BLINKING AND MILD

PTOSIS FOR SHORT TIME., DISSAPERED ITSELF

CONCLUSION-THE EFFECTIVITY OF THERAPY IS CONSTANT,BUT RELIEF I USUALLY TEMPORARY HENCE REPEATED

INJECTIONS ARE REQUIRED. MAY BE COMBINED WITH OTHER MODALITIES